Aug 8, 2018 Depomed Announces Second-Quarter 2018 Financial Results Depomed Announces Second-Quarter 2018 Financial ResultsRaises Full-Year Earnings and Adjusted EBITDA Guidance Range and. Lowers Full-Year Net Sales Guidance Range for the Neurology Franchise --. ... read morePublished on 2018-08-08